| The gut microbiota–brain axis in behaviour and brain disorders LH Morais, HL Schreiber IV, SK Mazmanian Nature Reviews Microbiology 19 (4), 241-255, 2021 | 1512 | 2021 |
| Enduring behavioral effects induced by birth by caesarean section in the mouse LH Morais, AV Golubeva, GM Moloney, A Moya-Pérez, AP Ventura-Silva, ... Current Biology 30 (19), 3761-3774. e6, 2020 | 92 | 2020 |
| Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration LH Morais, MMS Lima, BJ Martynhak, R Santiago, TT Takahashi, D Ariza, ... Pharmacological Reports 64 (5), 1081-1090, 2012 | 59 | 2012 |
| Strain differences in the susceptibility to the gut–brain axis and neurobehavioural alterations induced by maternal immune activation in mice LH Morais, D Felice, AV Golubeva, G Moloney, TG Dinan, JF Cryan Behavioural pharmacology 29 (2 and 3), 181-198, 2018 | 44 | 2018 |
| Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease JK Barbiero, RM Santiago, MMS Lima, D Ariza, LH Morais, R Andreatini, ... Behavioural brain research 216 (1), 186-192, 2011 | 43 | 2011 |
| A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice R Abdel-Haq, JCM Schlachetzki, JC Boktor, TM Cantu-Jungles, T Thron, ... Elife 11, e81453, 2022 | 42 | 2022 |
| Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson’s disease LH Morais, DB Hara, MA Bicca, A Poli, RN Takahashi Behavioural pharmacology 29 (2 and 3), 199-210, 2018 | 41 | 2018 |
| Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood BJ Martynhak, D Correia, LH Morais, P Araujo, ML Andersen, MMS Lima, ... Behavioural brain research 222 (1), 10-14, 2011 | 34 | 2011 |
| Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders C Gubert, J Gasparotto, L H. Morais Gastroenterology Report 10, goac017, 2022 | 32 | 2022 |
| The precarious position of postdocs during COVID-19 AHP M. Arslan Ahmed, Amir H. Behbahani, Adrian Brückner, Caroline J ... Science 368, 957-958, 2020 | 32 | 2020 |
| Envolvimento da flora intestinal na modulação de doenças psiquiátricas G Lach, LH Morais, APR Costa, AA Hoeller VITTALLE-Revista de Ciências da Saúde 29 (1), 64-82, 2017 | 27 | 2017 |
| Early-life oxytocin attenuates the social deficits induced by caesarean-section delivery in the mouse LH Morais, AV Golubeva, S Casey, KA Scott, AP Ramos Costa, ... Neuropsychopharmacology 46 (11), 1958-1968, 2021 | 22 | 2021 |
| Altered stress responses in adults born by Caesarean section TG Dinan, PJ Kennedy, LH Morais, A Murphy, CM Long-Smith, ... Neurobiology of Stress 16, 100425, 2022 | 19 | 2022 |
| Targeting the gut microbiota in Chagas disease: what do we know so far? E Duarte-Silva, LH Morais, G Clarke, W Savino, C Peixoto Frontiers in Microbiology 11, 585857, 2020 | 12 | 2020 |
| Schreiber HL t., Mazmanian SK (2020) LH Morais The gut microbiota-brain axis in behaviour and brain disorders. Nat. Rev …, 0 | 12 | |
| Enduring neurobehavioural effects in mice induced by early-life microbiota-gut-brain axis disruption: reversal by oxytocin L Morais, PJ Kannedy, G Moloney, AV Golubeva, K Rea, Y Borre, ... European Neuropsychopharmacology 1 (27), S37-S38, 2017 | 3 | 2017 |
| Riscos da automedicação MEM ANGELUCCI Cadernos Pedagógicos. Universidade Federal do Paraná Pró-Reitoria de …, 2005 | 3 | 2005 |
| The gut microbiome in animal models of Parkinson’s disease LH Morais, M de Castro Fonseca, TR Sampson Integrative Omics in Parkinson's Disease, 153-169, 2025 | 1 | 2025 |
| Quantitative bulk transcriptomics LH Morais | | 2024 |
| α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice LH Morais, JC Boktor, S MahmoudianDehkordi, R Kaddurah-Daouk, ... npj Parkinson's Disease 10 (1), 208, 2024 | | 2024 |